Background: The aim of the study was to verify the hypothesis that in diabetes there is an increased activation of coagulation system leading in consequence to diabetic retinopathy.

Methods: Thirty three healthy subjects (controls, 16 males and 17 females) and 35 patients with diabetes type 1 (15 males and 20 females) were examined. We monitored plasma prekallikrein (PPK), glycemia, fructosamine, glycosylated hemoglobin, activated partial thromboplastin time (PTT), INR, fibrinolysis in euglobulins time (FET), level of antithrombin III (AT III), fibrinogen (Fb) and fibrinogen degradation products (FDP).

Results: In diabetic patients without retinopathy, PKK concentration was 16% higher (p <0.005), in patients with background retinopathy 33% higher (p <0.001), and in patients with proliferative retinopathy PKK concentration was 50% higher (p <0.001) than in controls. In the subgroup of patients with proliferative retinopathy PTT was significantly shorter (p <0.001), and FET was significantly longer (p <0.001) than in control. In patients with diabetes higher FDP concentrations were found than in controls (p <0.05). Significant correlations were found between PPK and fructosamine levels in all diabetic patients (R(S)=+0.57 p <0.001), in diabetic patients without retinopathy (R(S)=+0.61, p <0.05), and in diabetic patients with retinopathy (R(S)=+0.62, p <0.005). We found negative correlation between PPK concentration and PTT (R(S)=-0.43, p <0.001) and positive correlation between PPK concentration and FET (R(S)=+0.59, p <0.00001) in the entire study group.

Conclusions: The occurrence of diabetic retinopathy is connected with higher levels of plasma prekallikrein.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.arcmed.2005.03.050DOI Listing

Publication Analysis

Top Keywords

plasma prekallikrein
8
males females
8
prekallikrein risk
4
risk factor
4
factor diabetic
4
diabetic retinopathy
4
retinopathy background
4
background aim
4
aim study
4
study verify
4

Similar Publications

Lipopolysaccharide (LPS) is the primary pathogenic factor in Gram-negative sepsis. While the presence of LPS in the bloodstream during infection is associated with disseminated intravascular coagulation, the mechanistic link between LPS and blood coagulation activation remains ill-defined. The contact pathway of coagulation-a series of biochemical reactions that initiates blood clotting when plasma factors XII (FXII) and XI (FXI), prekallikrein (PK) and high molecular weight kininogen (HK) interact with anionic surfaces-has been shown to be activated in Gram-negative septic patients.

View Article and Find Full Text PDF

Background And Objectives: Patients with rare diseases like hereditary angioedema (HAE) are usually referred to an angioedema center to ensure guideline-compliant and experience-based therapy. Even though there are established guidelines and several approved therapeutics, there are still open questions and situations in the daily care of HAE patients, where an exchange between centers is needed.

Materials And Methods: A survey was conducted among physicians from German angioedema centers regarding challenges and issues in everyday HAE treatment.

View Article and Find Full Text PDF

Hereditary angioedema (HAE) in children and adolescents: New treatment options.

Allergol Select

October 2024

Hannover Medical School (MHH), Department of Dermatology, Allergology and Venereology, Interdisciplinary Allergy Center of the MHH, Treatment Center for Hereditary Angioedema of the MHH, Hannover, Germany.

Article Synopsis
  • Modern management of hereditary angioedema (HAE) emphasizes personalized treatment plans tailored to the needs of children and adolescents, as well as the severity of the disease.
  • New medications have improved quality of life for HAE patients, but not all are approved for children, leading to ongoing research into alternative treatments such as those targeting bradykinin effects.
  • Emerging options like oral medications, long-acting therapies, and potential gene therapy are being explored to better meet the care requirements for young patients with HAE type I and II.
View Article and Find Full Text PDF
Article Synopsis
  • Cleaved high-molecular-weight kininogen (HKa) serves as a biomarker for the activation of the kallikrein-kinin system (KKS) in patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-C1INH).
  • The study aimed to create an HKa-specific enzyme-linked immunosorbent assay (ELISA) for monitoring KKS activation in the blood of HAE-C1INH patients, utilizing a specific antibody found through phage display.
  • Results showed that HKa levels were significantly higher in HAE-C1INH patients during attacks compared to healthy controls, indicating the potential of this ELISA for advancing drug development and understanding related diseases.
View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on two Chinese families with deficiencies in prokallikrein (PK) and High Molecular Weight Kininogen (HMWK), aiming to analyze their genetic variants and laboratory phenotypes.
  • Researchers collected clinical data, determined coagulation indexes, and conducted genomic sequencing of key genes (KLKB1 and KNG1) to identify mutations.
  • Findings revealed specific pathogenic variants in both families, linking genetic changes to the observed coagulation disorders, with implications for understanding these deficiencies.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!